CAV1 and prostate carcinoma: Collectively, these findings indicate that prostate cancer cells robustly secrete Cav-1-containing sphingolipid-enriched EVs33 that are enriched in a diverse repertoire of proteins including mitochondrial-associated proteins and lipids.